"[Repeat] testing and counseling is one of the key [services] that the government should continue providing": participants' perceptions on extended repeat HIV testing and enhanced counseling (ERHTEC) for primary HIV prevention in pregnant and lactating women in the PRIMAL study, Uganda.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
15 May 2020
Historique:
received: 12 06 2019
accepted: 20 04 2020
entrez: 17 5 2020
pubmed: 18 5 2020
medline: 24 10 2020
Statut: epublish

Résumé

The 'Primary HIV Prevention among Pregnant and Lactating Ugandan Women' (PRIMAL) randomized controlled trial aimed to assess an enhanced counseling strategy linked to extended postpartum repeat HIV testing and enhanced counseling among 820 HIV-negative pregnant and lactating women aged 18-49 years and 410 of their male partners to address the first pillar of the WHO Global Strategy for the Prevention of Mother-to-Child HIV transmission (PMTCT). This paper presents findings of qualitative studies aimed at evaluating participants' and service providers' perceptions on the acceptability and feasibility of the intervention and at understanding the effects of the intervention on risk reduction, couple communication, and emotional support from women's partners. PRIMAL Study participants were enrolled from two antenatal care clinics and randomized 1:1 to an intervention or control arm. Both arms received repeat sexually transmitted infections (STI) and HIV testing at enrolment, labor and delivery, and at 3, 6, 12, 18 and 24 months postpartum. The intervention consisted of enhanced quarterly counseling on HIV risk reduction, couple communication, family planning and nutrition delivered by study counselors through up to 24 months post-partum. Control participants received repeat standard post-test counseling. Qualitative data were collected from intervention women participants, counsellors and midwives at baseline, midline and end of the study through 18 focus group discussions and 44 key informant interviews. Data analysis followed a thematic approach using framework analysis and a matrix-based system for organizing, reducing, and synthesizing data. At baseline, FGD participants mentioned multiple sexual partners and lack of condom use as the main risks for pregnant and lactating women to acquire HIV. The main reasons for having multiple sexual partners were 1) the cultural practice not to have sex in the late pre-natal and early post-natal period; 2) increased sexual desire during pregnancy; 3) alcohol abuse; 4) poverty; and 5) conflict in couples. Consistent condom use at baseline was limited due to lack of knowledge and low acceptance of condom use in couples. The majority of intervention participants enrolled as couples felt enhanced counselling improved understanding, faithfulness, mutual support and appreciation within their couple. Another benefit mentioned by participants was improvement of couple communication and negotiation, as well as daily decision-making around sexual needs, family planning and condom use. Participants stressed the importance of providing counselling services to all couples. This study shows that enhanced individual and couple counselling linked to extended repeat HIV and STI testing and focusing on HIV prevention, couple communication, family planning and nutrition is a feasible and acceptable intervention that could enhance risk reduction programs among pregnant and lactating women. ClinicalTrials.gov registration number NCT01882998, date of registration 21st June 2013.

Sections du résumé

BACKGROUND BACKGROUND
The 'Primary HIV Prevention among Pregnant and Lactating Ugandan Women' (PRIMAL) randomized controlled trial aimed to assess an enhanced counseling strategy linked to extended postpartum repeat HIV testing and enhanced counseling among 820 HIV-negative pregnant and lactating women aged 18-49 years and 410 of their male partners to address the first pillar of the WHO Global Strategy for the Prevention of Mother-to-Child HIV transmission (PMTCT). This paper presents findings of qualitative studies aimed at evaluating participants' and service providers' perceptions on the acceptability and feasibility of the intervention and at understanding the effects of the intervention on risk reduction, couple communication, and emotional support from women's partners.
METHODS METHODS
PRIMAL Study participants were enrolled from two antenatal care clinics and randomized 1:1 to an intervention or control arm. Both arms received repeat sexually transmitted infections (STI) and HIV testing at enrolment, labor and delivery, and at 3, 6, 12, 18 and 24 months postpartum. The intervention consisted of enhanced quarterly counseling on HIV risk reduction, couple communication, family planning and nutrition delivered by study counselors through up to 24 months post-partum. Control participants received repeat standard post-test counseling. Qualitative data were collected from intervention women participants, counsellors and midwives at baseline, midline and end of the study through 18 focus group discussions and 44 key informant interviews. Data analysis followed a thematic approach using framework analysis and a matrix-based system for organizing, reducing, and synthesizing data.
RESULTS RESULTS
At baseline, FGD participants mentioned multiple sexual partners and lack of condom use as the main risks for pregnant and lactating women to acquire HIV. The main reasons for having multiple sexual partners were 1) the cultural practice not to have sex in the late pre-natal and early post-natal period; 2) increased sexual desire during pregnancy; 3) alcohol abuse; 4) poverty; and 5) conflict in couples. Consistent condom use at baseline was limited due to lack of knowledge and low acceptance of condom use in couples. The majority of intervention participants enrolled as couples felt enhanced counselling improved understanding, faithfulness, mutual support and appreciation within their couple. Another benefit mentioned by participants was improvement of couple communication and negotiation, as well as daily decision-making around sexual needs, family planning and condom use. Participants stressed the importance of providing counselling services to all couples.
CONCLUSION CONCLUSIONS
This study shows that enhanced individual and couple counselling linked to extended repeat HIV and STI testing and focusing on HIV prevention, couple communication, family planning and nutrition is a feasible and acceptable intervention that could enhance risk reduction programs among pregnant and lactating women.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov registration number NCT01882998, date of registration 21st June 2013.

Identifiants

pubmed: 32414405
doi: 10.1186/s12889-020-08738-x
pii: 10.1186/s12889-020-08738-x
pmc: PMC7227345
doi:

Banques de données

ClinicalTrials.gov
['NCT01882998']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

694

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD070767
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH109337
Pays : United States
Organisme : Foundation for the National Institutes of Health
ID : R01HD070767

Investigateurs

Michael Adengo (M)
Regina Adoo (R)
Sandra Agondeze (S)
Phiona Agwalo (P)
Mirriam Ajok (M)
Concy Akot (C)
Chiara Akumu (C)
Sharon Amama (S)
Josephine Aparo (J)
Pamela Atim (P)
Joshua Buule (J)
Lynae Darbes (L)
Alice Elwana (A)
Elizabeth Kakande (E)
Elly Katabira (E)
Ruth Kayondo (R)
Grace Kezaabu (G)
Beatrice Kibuuka (B)
Max Kiwewa (M)
Justine Lagol (J)
Emily Likico Opu (EL)
Sarah Lunkuse (S)
Joyce Matovu (J)
Kenneth Mwambi (K)
Josephine Nabukenya (J)
Sarah Nakabuye (S)
Noor Nakigozi (N)
Gorrethy Nalubega (G)
Esther Nambi (E)
Halima Namukasa (H)
Christine Namulwasike (C)
Brenda Namusoke (B)
Maria Nansasi (M)
Irene Viola Nantongo (IV)
Vivian Ntono (V)
Florence Ochan (F)
Juliet Ogwang (J)
Lawrence Ojom (L)
Michael Okwera (M)
David Oryema (D)
Erick Otema (E)
Betty Oweka (B)
Joyce Rwechungura (J)
Gertrude Sentongo (G)
Jane Ssebaggala (J)
Ruth Ssentongo (R)
Anitah Wanyana (A)

Références

AIDS. 2003 Mar 28;17(5):733-40
pubmed: 12646797
Reprod Health Matters. 2004 May;12(23):129-31
pubmed: 15242220
Sex Transm Infect. 2016 Dec;92(8):579-586
pubmed: 27531527
AIDS Care. 2010 Sep;22(9):1041-51
pubmed: 20824557
Reprod Health. 2015 Oct 15;12:95
pubmed: 26472575
BMC Public Health. 2020 May 15;20(1):694
pubmed: 32414405
J Affect Disord. 2013 Nov;151(2):715-721
pubmed: 24012069
BMC Public Health. 2017 Jan 23;17(1):104
pubmed: 28114968
Expert Opin Drug Saf. 2016;15(2):265-73
pubmed: 26634852
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):417-425
pubmed: 28426440
BMC Public Health. 2010 Dec 17;10:769
pubmed: 21167040
J Pregnancy. 2017;2017:4758017
pubmed: 28243473
Crisis. 2012 Jan 1;33(2):95-105
pubmed: 22343055
Reprod Health Matters. 2006 Nov;14(28):89-98
pubmed: 17101426
PLoS One. 2015 Sep 18;10(9):e0136531
pubmed: 26384103
Lancet. 2005 Oct 1;366(9492):1182-8
pubmed: 16198767
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):e138-45
pubmed: 23274930
Glob Health Action. 2015 Jun 08;8:27935
pubmed: 26058858
JAMA. 2014 Jul 23-30;312(4):362-71
pubmed: 25038355
AIDS Care. 2012;24(4):444-50
pubmed: 22085286
Postgrad Med J. 2005 May;81(955):273-5
pubmed: 15879036
S Afr J Psychiatr. 2018 Jun 05;24:1136
pubmed: 30263215
J Int AIDS Soc. 2011 Sep 13;14:43
pubmed: 21914207
PLoS One. 2019 Feb 25;14(2):e0212119
pubmed: 30802277
Afr J Reprod Health. 2001 Dec;5(3):15-28
pubmed: 12471926
Reprod Health Matters. 2004 May;12(23):132-5
pubmed: 15242221
Reprod Health. 2010 Jun 23;7:12
pubmed: 20573250
BMC Public Health. 2007 Dec 11;7:349
pubmed: 18072974
PLoS Med. 2016 Sep 27;13(9):e1002132
pubmed: 27676257
AIDS Behav. 2013 Mar;17(3):1025-39
pubmed: 23128978

Auteurs

Femke Bannink Mbazzi (F)

Medical Research Council / Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine Uganda Research Unit, P.O. Box 49, Entebbe, Uganda. femke.bannink@mrcuganda.org.
Faculty of Psychology and Educational Sciences, Ghent University, Ghent, Belgium. femke.bannink@mrcuganda.org.

Zikulah Namukwaya (Z)

Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.

Alexander Amone (A)

Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.

Francis Ojok (F)

AVSI Foundation, Kampala, Uganda.

Juliane Etima (J)

Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.

Josaphat Byamugisha (J)

Department of Obstetrics and Gynecology, Makerere University School of Medicine, Kampala, Uganda.

Elly Katabira (E)

Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.
College of Health Sciences, School of Medicine, Makerere University, Kampala, Uganda.

Mary Glenn Fowler (MG)

Makerere University - Johns Hopkins University Research Collaboration, Kampala, Uganda.
Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.

Jaco Homsy (J)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.

Rachel King (R)

Institute for Global Health Sciences, University of California, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH